Results 161 to 170 of about 2,555,654 (307)

Advancements and prospects in bioinformatics and omics for colorectal cancer: A dual bibliometric analysis of global trends and top cited publications

Journal of Intelligent Medicine, EarlyView.
This dual bibliometric analysis examined 5129 publications and the top 100 most cited publications on bioinformatics and omics in colorectal cancer (2004–2025) from the Web of Science Core Collection. Using SCImago Graphica, VOSviewer, CiteSpace, and R Studio, we analyzed global trends, countries/regions, institutions, journals, authors, references ...
Yue Huang, Ziye Peng, Xiangyu Wang, Likun Yang, Yifei Gao, Ximo Wang, Jiaxin Li, Zhengcun Pei   +7 more
wiley   +1 more source

A Case of Duffy-Null-Associated Neutropenia in a Patient With Chronic Myeloid Leukemia. [PDF]

Case Rep Hematol
Parekh A, Metzner-Sadurski J.
europepmc   +1 more source

Nail Toxicities Associated With Anticancer Therapies in Children

JEADV Clinical Practice, EarlyView.
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley   +1 more source

Investigation of selected MiRNA as potential biomarker in chronic myeloid leukemia patients. [PDF]

Med Pharm Rep
Alqaraleh M, Alhmoud JF, Dababneh II, Odeh NL, Dala-Ali SN, Alhiary LS, Al-Rawashde FA.   +6 more
europepmc   +1 more source

First-line therapy of chronic myeloid leukemia – focus on dasatinib

, 2012
Philip C AmreinHematology-Oncology, Massachusetts General Hospital, Boston, USAAbstract: Dasatinib is a broad spectrum, ATP-competitive, tyrosine kinase inhibitor with low nM activity against Bcr-Abl, Src, and other tyrosine kinases.
Amrein PC
core  

Immunological mechanisms and therapeutic advances in chronic myeloid leukemia. [PDF]

Leukemia
Ybarra TK, Sathianathen RS, Hamidi R, Hijiya N, Shah NP, Sakamoto KM.   +5 more
europepmc   +1 more source

CHRONIC MYELOID LEUKEMIA

Nihon Naika Gakkai Zasshi, 1980
openaire   +3 more sources

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

Prevention of Early Onset of Breast Cancer With Ashwagandha

Molecular Carcinogenesis, EarlyView.
ABSTRACT Prevention of breast cancer is feasible because many risk factors for this malignancy are known (e.g., family history, reproductive factors, etc.). Medicinal plants and/or their bioactive phytochemicals are attractive for the prevention of early onset of breast cancer due to their generally favorable safety profile.
Eun‐Ryeong Hahm, Su‐Hyeong Kim, Shivendra V. Singh   +2 more
wiley   +1 more source

Concurrent BCR::ABL1 and SET::NUP214 fusions in blast-phase chronic myeloid leukemia. [PDF]

Cancer Genet
Manoharan M, Alnoor F, Yang P, Amador-Ortiz C, Beitinjaneh A, Venugopal S, Wang X, Zhou Y, Ruiz-Cordero R, Chapman J, Novoa F, Madarang E, Watts J, Taylor J.   +13 more
europepmc   +1 more source